Delivery Order SPE2DB22D3004-SPE2DB25FRN02
- Not listed
- The Defense Logistics Agency awarded a $11,174.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Xeomin 200 Unit Vials, with completion scheduled for August 8, 2025. This competitively awarded contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for XEOMIN 100 Unit vials with a ceiling value of $8,381.10. This firm fixed price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) valued at $999,999,999.00 through December 2026. The award was made on a competitive basis with no set-aside designation,...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $13,106 firm fixed price delivery order contract to provide 200 units of Xeomin, a botulinum toxin used for medical treatments. As the prime contractor, Amerisourcebergen will deliver the products to a location in Conshohocken, Pennsylvania by August 4, 2023 after the July 14 period of performance start date. No subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely contracts for...
- The Defense Logistics Agency awarded a $31,454 delivery order to Amerisourcebergen Drug Corporation for 200 units of Xeomin, a botulinum toxin used for medical treatments. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location through August 1, 2023 to support the Department of Defense. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the global supply chain for the United States military and this...
- The Defense Logistics Agency awarded a $10,484.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 units of Xeomin, a botulinum toxin used for medical treatments. To be performed in Conshohocken, Pennsylvania from August 9-30, 2023, this order is funded through DLA's portfolio of contracts for pharmaceuticals and medical supplies supporting the Department of Defense. As a top 10 federal contractor, Amerisourcebergen will deliver the products from its corporate...
- This is a $25,164 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of the prescription drug Xeomin. The contract is a firm-fixed-price delivery order with a period of performance through September 2024. There are no set-aside requirements for this contract. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical,...
- The Defense Logistics Agency Troop Support Medical awarded a $2,621.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin, a botulinum toxin used for medical treatments. The contract has a period of performance from July 3, 2023 through July 25, 2023, with all work to be completed at Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. This delivery order was issued under an...
- This delivery order for $7,863.75, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, is for the delivery of 200 units of Xeomin, a botulinum toxin used for medical purposes. The contract has a firm fixed price and period of performance through November 6, 2023. To be delivered to a location in Conshohocken, Pennsylvania, this order was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle but did not have a set-aside designation. The...
- The Defense Logistics Agency Troop Support Medical awarded a $44,036 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin, a botulinum toxin. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is from July 27, 2023 through August 17, 2023. No major subcontractors or set aside designations were identified. This delivery order was issued under an existing...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $44,036.16 to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. Performance will take place in Conshohocken, Pennsylvania over a period from August 31, 2023 through September 22, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for a botulinum toxin appears to support the Agency's mission to provide critical medical logistics...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRN02Delivery Order
The Defense Logistics Agency awarded a $46,934.16 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin on July 18, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs worldwide. Xeomin, a botulinum toxin product used for medical applications, falls within the range of specialty pharmaceutical products that AmerisourceBergen supplies through its federal contract portfolio. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen regularly fulfills orders for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its DLA framework agreement. This delivery order exemplifies the company's ongoing role in supplying specialized medical commodities to support military and veteran healthcare requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.9k | 7/18/25 |